Prospect Capital Corp(PBC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PBC Prospect Capital Corp

退市 04-16 09:30:50 EDT

25.06

+0.00

0.00%

最高25.06	最低25.06	成交量0.00
今开25.06	昨收25.06	日振幅0.00%
总市值92.18亿	流通市值0.00	总股本3.68亿
成交额31.97万	换手率--	流通股本0.00
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PBC","market":"US","secType":"STK","nameCN":"Prospect Capital Corp","latestPrice":25.06,"timestamp":1640811600000,"preClose":25.06,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":367817926,"eps":0.367626,"marketStatus":"退市","change":0,"latestTime":"04-16 09:30:50 EDT","open":25.06,"high":25.06,"low":25.06,"amount":319705.1613,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.367626,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1776369600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":25.06,"dividendRate":0.028731,"volumeRatio":0},"requestUrl":"/m/hq/s/PBC","defaultTab":"news","newsList":[{"id":"2620022594","title":"OpenAI冲刺年底IPO：砍掉支线业务全力为企业变现，2030年收入剑指2800亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620022594","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620022594?lang=zh_cn&edition=full","pubTime":"2026-03-18 08:45","pubTimestamp":1773794730,"startTime":"0","endTime":"0","summary":"知情人士透露，OpenAI首次公开募股最快或于今年年底前启动，但具体时间仍存调整可能。据此前报道，OpenAI首席执行官萨姆·奥尔特曼曾大力宣扬的1.4万亿美元投资目标，已在2月份向投资者沟通时调整为——到2030年实现约6000亿美元的总计算支出规模。OpenAI最新预测显示，2030年总收入将突破2800亿美元，其中消费者业务与企业业务的贡献占比将基本持平。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPO","PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611116168","title":"Tharimmune, Inc.盘中异动 早盘急速拉升5.14%报4.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611116168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611116168?lang=zh_cn&edition=full","pubTime":"2026-02-14 00:15","pubTimestamp":1770999328,"startTime":"0","endTime":"0","summary":"北京时间2026年02月14日00时15分，Tharimmune, Inc.股票出现波动，股价快速上涨5.14%。截至发稿，该股报4.50美元/股，成交量11.1782万股，换手率0.28%，振幅6.54%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为2.04%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021400152897a62334&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021400152897a62334&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CNTN","BK4139","PBC","THAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593246855","title":"吉利德：原发性胆汁性胆管炎药物Seladelpar在海南博鳌乐城获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2593246855","media":"人民财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593246855?lang=zh_cn&edition=full","pubTime":"2025-12-23 10:45","pubTimestamp":1766457935,"startTime":"0","endTime":"0","summary":"【吉利德：原发性胆汁性胆管炎药物Seladelpar在海南博鳌乐城获批】12月22日，吉利德原发性胆汁性胆管炎(PBC)药物Seladelpar在海南博鳌乐城国际医疗旅游先行区获批，适用于与熊去氧胆酸（UDCA）联合治疗对UDCA单药应答不佳的PBC成人患者，或作为单药用于治疗无法耐受UDCA的PBC成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/a/202512233599290123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593430618","title":"Tharimmune, Inc.盘中异动 早盘股价大涨9.48%报2.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593430618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593430618?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:31","pubTimestamp":1766413907,"startTime":"0","endTime":"0","summary":"北京时间2025年12月22日22时31分，Tharimmune, Inc.股票出现波动，股价快速拉升9.48%。截至发稿，该股报2.54美元/股，成交量21.4924万股，换手率0.61%，振幅2.15%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223147a46ae19c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222223147a46ae19c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","BK4139","PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582373562","title":"Tharimmune, Inc.盘中异动 临近午盘股价大跌6.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582373562","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582373562?lang=zh_cn&edition=full","pubTime":"2025-11-12 00:30","pubTimestamp":1762878642,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日00时30分，Tharimmune, Inc.股票出现异动，股价快速下挫6.46%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为1.24%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112003042a49a46ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112003042a49a46ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","BK4139","THAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582624908","title":"吉利德“进博会”达成多项合作 推动健康公平可及","url":"https://stock-news.laohu8.com/highlight/detail?id=2582624908","media":"中国网财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582624908?lang=zh_cn&edition=full","pubTime":"2025-11-08 18:52","pubTimestamp":1762599120,"startTime":"0","endTime":"0","summary":"中国网财经11月8日讯 第八届进博会期间，吉利德科学签署多项战略合作协议。吉利德科学全球副总裁、中国区总经理金方千表示，进入中国八年多来，吉利德始终以患者为中心，推动全球创新疗法快速惠及中国患者。截至目前，在中国正式获批的13款创新药物已累计惠及约180万患者。“依托进博会这一开放平台，我们持续拓展合作网络，推动扩大创新药物可及，提升患者的治疗体验和生活质量。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110819201294f79163&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110819201294f79163&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581777998","title":"（第八届进博会）跨国药企深耕进博会 加速创新成果落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2581777998","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581777998?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:40","pubTimestamp":1762353653,"startTime":"0","endTime":"0","summary":"中新社上海11月5日电(记者陈静)“过去七年，从展品到商品，再到临床广泛可及，进博会已成为创新药物加速惠及中国患者的重要催化平台。”诺华公司中国区副总裁，心血管、肾脏及代谢治疗领域兼创新患者服务负责人管宏5日对记者表示，得益于进博会的溢出效应，诺华公司多款心肾领域的创新药物实现首秀到落地的跨越。第八届中国国际进口博览会5日开幕。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511053556163538.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511053556163538.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1778281490.HKD","PBC","LU1571399168.USD","LU0882574055.USD","LU0289739699.SGD","06978","LU0320765992.SGD","LU0058720904.USD","SG9999015945.SGD","BK4566","IE0002270589.USD","BK1161","SG9999015952.SGD","LU1585245621.USD","LU0234570918.USD","BK4588","LU1430594728.SGD","LU1839511570.USD","LU1066053197.SGD","LU1674673428.USD","LU0109394709.USD","IE00B19Z3B42.SGD","BK4532","IE00BKVL7J92.USD","LU2468319806.SGD","BK4578","BK4568","BK4585","BK4583","LU0114720955.EUR","SG9999015986.USD","IE00B19Z3581.USD","GILD","LU2089984988.USD","LU1066051498.USD","IE00BSNM7G36.USD","BK4550","LU2087621335.USD","SG9999015978.USD","LU0889565916.HKD","LU0823416689.USD","BK4139","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU1674673691.USD","BK1574","IE00B7SZLL34.SGD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581720929","title":"进博观察：开放平台引“凤”来，医疗药械焕新健康动能","url":"https://stock-news.laohu8.com/highlight/detail?id=2581720929","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581720929?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:31","pubTimestamp":1762345866,"startTime":"0","endTime":"0","summary":"11月5日，第八届中国国际进口博览会（下称“进博会”）在上海盛大开幕。本届进博会吸引155个国家、地区和国际组织赴约，4108家境外企业带来最新成果，43万平方米展馆汇聚全球智慧，进博规模再创新高。自2018年首届以来，进博会已逐步强化国际采购、投资促进、人文交流、开放合作“四大平台”功能，成为全球瞩目的开放合作盛会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202511053556078911.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511053556078911.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581715385","title":"吉利德四赴进博会：全球首款长效HIV预防药亚洲首秀","url":"https://stock-news.laohu8.com/highlight/detail?id=2581715385","media":"南方都市报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581715385?lang=zh_cn&edition=full","pubTime":"2025-11-04 13:24","pubTimestamp":1762233852,"startTime":"0","endTime":"0","summary":"从“展品”到“药品”，从“首展”到“首用”，吉利德科学借进博会“黄金跑道”持续跑出“中国速度”。11月展台现场，吉利德将首次在亚洲公开展示这一全新的HIV预防方案，并同步披露其在全球同步研发框架下中国参与项目的最新进展——10项肿瘤、6项非肿瘤研究中，90%的肿瘤项目已实现与全球“零时差”开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104132704a6df8bb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104132704a6df8bb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","LU2468319806.SGD","BK4578","LU0109394709.USD","BK4588","IE00BSNM7G36.USD","LU0058720904.USD","SG9999015952.SGD","BK4568","SG9999015945.SGD","IE00BZ1G4Q59.USD","BK4585","LU0882574055.USD","IE00B3T34201.USD","LU1778281490.HKD","LU2089984988.USD","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU1066053197.SGD","LU1674673691.USD","LU2324357040.USD","BK4550","LU1066051498.USD","LU1430594728.SGD","LU2087621335.USD","BK4139","GILD","LU0889565916.HKD","SG9999015978.USD","SG9999015986.USD","LU1839511570.USD","IE0002270589.USD","LU0823416689.USD","PBC","LU0234570918.USD","IE00B7SZLL34.SGD","LU1674673428.USD","BK4566","LU0320765992.SGD","BK4532","LU0289739699.SGD","LU1571399168.USD","LU1585245621.USD","IE00B19Z3B42.SGD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577307068","title":"跨国药企高层：进博会强大“溢出效应”成全球创新成果落地“加速器”","url":"https://stock-news.laohu8.com/highlight/detail?id=2577307068","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577307068?lang=zh_cn&edition=full","pubTime":"2025-10-23 21:06","pubTimestamp":1761224803,"startTime":"0","endTime":"0","summary":"中新网上海10月23日电(记者陈静)“进博会已成为全球新品首发、技术首秀和共享中国机遇的重要平台。过去连续三年参展，我们深切感受到进博会的‘溢出效应’，多款创新疗法通过‘进博快车’加速落地，更快惠及中国患者。”吉利德科学全球副总裁、中国区总经理金方千23日对记者表示。第八届中国国际进口博览会(简称：进博会)将要开幕，全球领先的生物制药企业吉利德科学将第四次亮相进博会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510233542559744.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510233542559744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["SG9999015986.USD","LU0320765992.SGD","SG9999015945.SGD","LU1430594728.SGD","LU1066051498.USD","IE00B19Z3581.USD","LU1839511570.USD","BK4532","LU0289739699.SGD","IE00BZ1G4Q59.USD","BK4585","LU1571399168.USD","IE0002270589.USD","LU0234570918.USD","IE00BSNM7G36.USD","IE00B3T34201.USD","BK4578","BK4588","LU1674673428.USD","LU0882574055.USD","IE00B7SZLL34.SGD","BK4568","LU0109394709.USD","BK4550","LU2468319806.SGD","BK4583","LU1585245621.USD","LU2324357040.USD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","SG9999015952.SGD","SG9999015978.USD","LU1778281490.HKD","GILD","LU0114720955.EUR","BK4566","LU1066053197.SGD","PBC","BK4139","LU1674673691.USD","LU0889565916.HKD","LU2087621335.USD","LU0058720904.USD","LU0823416689.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577306333","title":"吉利德13款新药加速惠及中国患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2577306333","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577306333?lang=zh_cn&edition=full","pubTime":"2025-10-23 19:16","pubTimestamp":1761218177,"startTime":"0","endTime":"0","summary":"第八届中国国际进口博览会将于11月5日在上海开幕，吉利德科学将第四次亮相这一盛会。吉利德科学全球副总裁、中国区总经理金方千表示：“进博会已成为全球新品首发、技术首秀和共享中国机遇的重要平台。过去连续三年参展，我们深切感受到进博会的溢出效应，多款创新疗法通过‘进博快车’加速落地，更快惠及中国患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510233542486544.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06978","BK1161","BK1574","PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577387943","title":"Tharimmune, Inc.盘中异动 股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577387943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577387943?lang=zh_cn&edition=full","pubTime":"2025-10-21 21:59","pubTimestamp":1761055143,"startTime":"0","endTime":"0","summary":"北京时间2025年10月21日21时59分，Tharimmune, Inc.股票出现异动，股价快速下挫5.38%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。其相关个股中，Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.涨幅较大，Minerva Neurosciences, Inc、Ibio, Inc.、Rani Therapeutics Holdings, Inc.较为活跃，换手率分别为1205.30%、166.31%、49.04%，振幅较大的相关个股有Minerva Neurosciences, Inc、Cero Therapeutics Holdings Inc C/Wts 14/02/2029 、Ibio, Inc.，振幅分别为215.34%、78.99%、47.03%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102121590394d5f53d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102121590394d5f53d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","THAR","PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2575477592","title":"Tharimmune, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575477592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575477592?lang=zh_cn&edition=full","pubTime":"2025-10-15 01:04","pubTimestamp":1760461453,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日01时04分，Tharimmune, Inc.股票出现异动，股价大幅上涨5.04%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Senti Biosciences, Inc.涨幅较大，Pmgc Holdings Inc.、Astria Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2802.30%、38.15%、37.55%，振幅较大的相关个股有Pmgc Holdings Inc.、Cdt Equity Inc C/Wts 22/09/2028、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com，振幅分别为55.85%、38.33%、37.50%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101501041394c91e45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101501041394c91e45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","BK4139","PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2574432962","title":"Tharimmune, Inc.盘中异动 早盘急速拉升5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574432962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574432962?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:39","pubTimestamp":1760107161,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日22时39分，Tharimmune, Inc.股票出现异动，股价大幅上涨5.38%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。其相关个股中，Gyre Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Q32 Bio Inc.涨幅较大，Aditxt, Inc.、Cdt Equity Inc.、Intensity Therapeutics, Inc.较为活跃，换手率分别为321.98%、70.15%、49.71%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Briacell Therapeutics Corp C/Wts 26/02/2026、知临集团，振幅分别为39.68%、33.20%、29.54%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，正在开发一系列用于治疗罕见免疫疾病、炎症疾病和肿瘤疾病的治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101022392194c204ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101022392194c204ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","BK4139","PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516670075","title":"Tharimmune, Inc.盘中异动 大幅下挫6.21%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670075?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:32","pubTimestamp":1741098734,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Tharimmune, Inc.股票出现异动，股价快速下挫6.21%。截至发稿，该股报1.36美元/股，成交量56.5869万股，换手率29.26%，振幅0.69%。Tharimmune, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223214a25f049a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223214a25f049a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PBC","BK4139","THAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514686977","title":"Tharimmune, Inc.盘中异动 下午盘快速上涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514686977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514686977?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:02","pubTimestamp":1740596538,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时02分，Tharimmune, Inc.股票出现异动，股价大幅上涨5.67%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6518.56%、288.25%、256.53%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Organovo Holdings, Inc.，振幅分别为194.07%、81.11%、52.76%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270302189631805d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270302189631805d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","THAR","PBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512662459","title":"外媒：OpenAI辉煌时代已经结束","url":"https://stock-news.laohu8.com/highlight/detail?id=2512662459","media":"鞭牛士Bianews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512662459?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:00","pubTimestamp":1739977239,"startTime":"0","endTime":"0","summary":"鞭牛士报道，2月19日消息，ITPro分析认为，OpenAI 的辉煌时代已经结束。OpenAI 曾经表现良好，但我认为，它备受关注的时代即将结束。目前尚不清楚此次重组将如何影响 OpenAI 的长期财务困境，但目前该公司的状况大致相同。例如，本月早些时候，竞争对手人工智能公司 Figure 宣布将终止与 OpenAI 的交易。这还有待观察，但很明显，OpenAI 不再是曾经的领跑者。DeepSeek 是该领域的新秀，它是一种全新的替代方案，让 OpenAI 看起来几乎过时了。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8h6rHRpjp8N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["LU0203202063.USD","IE0003U64NQ7.SGD","PBC","LU2041044095.USD","LU0170899867.USD","LU1267930730.SGD","LU2242650005.HKD","IE00BN8TJ469.HKD","LU1236620834.HKD","LU0056508442.USD","LU0894486033.HKD","LU2360032135.SGD","LU2092627202.USD","LU2505996509.AUD","SG9999014898.SGD","LU2092937221.SGD","IE0004445239.USD","BK4538","LU2023250504.SGD","LU0302445910.USD","LU1791710400.SGD","BK4585","LU1244550221.USD","IE00B19Z8W00.USD","LU0444971666.USD","LU0080751232.USD","LU0795875169.SGD","BK4535","MSFT","LU1043141396.HKD","LU0097036916.USD","SG9999015341.SGD","LU1914381329.SGD","BK4532","LU0316494557.USD","LU0784385840.USD","LU2213496289.HKD","LU1116320901.HKD","LU2471134796.USD","IE00BJJMRY28.SGD","LU0347712357.USD","LU1564329461.SGD","LU1861127337.USD","LU2237443978.SGD","LU2023250330.USD","LU2360108059.USD","LU0251132253.USD","LU0053666078.USD","LU0310800379.SGD","LU0149725797.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2506889898","title":"Tharimmune, Inc.盘中异动 股价大跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506889898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506889898?lang=zh_cn&edition=full","pubTime":"2025-01-25 00:24","pubTimestamp":1737735891,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日00时24分，Tharimmune, Inc.股票出现异动，股价快速下挫6.02%。Tharimmune, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Evaxion Biotech As、Neuphoria Therapeutics Inc.、Pmgc Holdings Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为3872.49%、2103.81%、1560.72%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Neuphoria Therapeutics Inc.，振幅分别为134.08%、112.09%、107.98%。Tharimmune, Inc.公司简介：Tharimmune Inc 是一家生物技术公司，开发针对罕见免疫、炎症和肿瘤疾病的候选治疗药物组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125002451abb76906&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125002451abb76906&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["THAR","PBC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505271269","title":"【美股太空概念股强势上涨 Rocket Lab涨超15%】美股太空概念股强势上涨，Redwire涨超18%，卫讯公司、Planet Labs PBC涨超17%，Rocket Lab涨超15%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2505271269","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505271269?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:41","pubTimestamp":1737470486,"startTime":"0","endTime":"0","summary":"美股太空概念股强势上涨，Redwire涨超18%，卫讯公司、Planet Labs PBC涨超17%，Rocket Lab涨超15%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1c8a81e67451b11a95c6db39ac88b8b4","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/21224147677448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4020","PBC","VSAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502564680","title":"大模型不再有信仰","url":"https://stock-news.laohu8.com/highlight/detail?id=2502564680","media":"三言财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502564680?lang=zh_cn&edition=full","pubTime":"2025-01-08 23:31","pubTimestamp":1736350303,"startTime":"0","endTime":"0","summary":"AI大模型的“AGI信仰”可能正处在崩溃边缘，与曾经的“区块链信仰”殊途同归。2025年，可能是AI大模型“信仰崩塌”元年。除了OpenAI，国内外其他大模型公司或多或少也都出现不同问题。2024年10月，AI大模型公司波形智能解散，多名团队核心成员入职OPPO。还有像Adept、Reka AI、Humane等大模型公司均遭遇不同程度的运营危机，已被收购或者正寻求出售。2025年各大模型公司应该会更加务实，还是那句话，只有活得下去才有实现目标的可能，“信仰”不再重要。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8fzFKx2Z2vL","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["PBC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.prospectstreet.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0354},{"period":"1month","weight":0.0462},{"period":"3month","weight":0.0111},{"period":"6month","weight":0.0535},{"period":"1year","weight":0.3019},{"period":"ytd","weight":0.0264}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Prospect Capital Corporation成立于2004年4月13日，是一家封闭式投资公司。公司是一家金融服务公司，主要向中等市场的私人控股公司提供贷款和投资。公司是一家在马里兰州注册成立的封闭式投资公司。其投资目标是通过债务和股权投资实现当期收益和长期资本增值。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.034529},{"month":2,"riseRate":0,"avgChangeRate":-0.031267},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.060348},{"month":4,"riseRate":1,"avgChangeRate":0.067548},{"month":5,"riseRate":0.333333,"avgChangeRate":0.002978},{"month":6,"riseRate":0.666667,"avgChangeRate":0.011102},{"month":7,"riseRate":0.666667,"avgChangeRate":0.009468},{"month":8,"riseRate":0.666667,"avgChangeRate":0.011194},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.002421},{"month":10,"riseRate":0.666667,"avgChangeRate":0.00649},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.002162},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.003597}],"exchange":"NYSE","name":"Prospect Capital Corp","nameEN":"Prospect Capital Corp"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Prospect Capital Corp(PBC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Prospect Capital Corp(PBC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Prospect Capital Corp,PBC,Prospect Capital Corp股票,Prospect Capital Corp股票老虎,Prospect Capital Corp股票老虎国际,Prospect Capital Corp行情,Prospect Capital Corp股票行情,Prospect Capital Corp股价,Prospect Capital Corp股市,Prospect Capital Corp股票价格,Prospect Capital Corp股票交易,Prospect Capital Corp股票购买,Prospect Capital Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Prospect Capital Corp(PBC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Prospect Capital Corp(PBC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}